Surinder Batra, PhD


phone: 402-559-5455


Associate Director, Nanovaccine Institute

Professor and Chairman, Department of Biochemistry & Molecular Biology, College of Medicine

Associate Director for Education and Training, Fred & Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer, University of Nebraska Medical Center

University of Nebraska Medical Center



PhD, Kurukshetra University (NDRI), INDIA, 1983

Stragier, L’institut national de la recherché agronomique (INRA)
Tours, France, 1982-83

Post-doctoral Fellow, North Carolina State University, Raleigh, NC, USA, 1983-1986

Research Associate Post-doctoral Fellow,  Duke University Medical Center, Durham, USA, 1988-1991

Research interest: Tumor-associated genes; cancer diagnostics, cancer vaccines; monoclonal antibodies, genetic engineering of antibodies.

The overall goals of our laboratory are to study the molecular mechanisms of neoplastic transformation, differentiation, and altered growth in human pancreatic, colorectal, prostate, and brain tumors. Normal cell proliferation is under the intrinsic control of growth-promoting proto-oncogenes and growth-constraining anti-oncogenes.

Specifically, we are defining the multifaceted roles of tumor-associated antigens (MUC4, MUC5AC, MUC16 (CA125), MUC17, and PD2/hPaf1) in the pathogenesis and targeting of multiple cancers.